If efficacy is proven to increase from the gemcitabine combo does escalation then I’d say it’s safe to say larger pharma companies would start looking at us. Gemcitabine is the standard care for pancreatic cancer, so we have the potential to capture a wide range of market when you consider using in combo… another 12-18 months this ticker maybe very different MC
- Forums
- ASX - By Stock
- ATX
- Ann: Change of Director's Interest Notice - Dr Christopher Burns
Ann: Change of Director's Interest Notice - Dr Christopher Burns, page-5
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.85M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.5¢ | $11.72K | 111.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 157497 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 157497 | 0.100 |
1 | 1856 | 0.098 |
1 | 50000 | 0.096 |
1 | 100000 | 0.095 |
1 | 109679 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 500 | 1 |
0.110 | 64000 | 1 |
0.130 | 2243 | 1 |
0.135 | 50005 | 1 |
0.140 | 173858 | 4 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
NEWS
First paediatric clinical site activated – major recruitment milestone and key appointment announced
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
ATX (ASX) Chart |